These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17656074)

  • 21. Effects of cytidine 5'-diphosphocholine (CDP-choline) on the thermal nociceptive threshold in streptozotocin-induced diabetic mice.
    Kamei J; Ohsawa M; Miyata S; Endo K; Hayakawa H
    Eur J Pharmacol; 2008 Nov; 598(1-3):32-6. PubMed ID: 18834878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
    Koda K; Ago Y; Kawasaki T; Hashimoto H; Baba A; Matsuda T
    Psychopharmacology (Berl); 2008 Feb; 196(2):293-301. PubMed ID: 17912499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers.
    Knott V; de la Salle S; Choueiry J; Impey D; Smith D; Smith M; Beaudry E; Saghir S; Ilivitsky V; Labelle A
    Pharmacol Biochem Behav; 2015 Apr; 131():119-29. PubMed ID: 25681529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological profiles of galantamine: the involvement of muscarinic receptor].
    Matsuda T; Ago Y; Takuma K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Feb; 32(1):1-8. PubMed ID: 22568120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation.
    Cavun S; Savci V; Ulus IH
    Fundam Clin Pharmacol; 2004 Feb; 18(1):71-7. PubMed ID: 14748757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acute dose and baseline amplitude-dependent effects of CDP-choline on deviance detection (MMN) in chronic schizophrenia: A pilot study.
    Aidelbaum R; Labelle A; Choueiry J; Knott V
    Exp Clin Psychopharmacol; 2022 Apr; 30(2):235-248. PubMed ID: 33630646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain.
    Kanat O; Bagdas D; Ozboluk HY; Gurun MS
    J BUON; 2013; 18(4):1012-8. PubMed ID: 24344031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke.
    Hurtado O; Cárdenas A; Pradillo JM; Morales JR; Ortego F; Sobrino T; Castillo J; Moro MA; Lizasoain I
    Neurobiol Dis; 2007 Apr; 26(1):105-11. PubMed ID: 17234423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology.
    Coyle JT; Geerts H; Sorra K; Amatniek J
    J Alzheimers Dis; 2007 Jul; 11(4):491-507. PubMed ID: 17656829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system.
    Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
    Eur J Pharmacol; 2008 Jul; 589(1-3):315-22. PubMed ID: 18561911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDP-choline as a biological supplement during neurorecovery: a focused review.
    Arenth PM; Russell KC; Ricker JH; Zafonte RD
    PM R; 2011 Jun; 3(6 Suppl 1):S123-31. PubMed ID: 21703569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of α7-nicotinic acetylcholine receptor in a rat model of chronic nicotine-induced mechanical hypersensitivity.
    Zhang Y; Sevilla A; Weller R; Wang S; Gitlin MC; Candiotti KA
    Neurosci Lett; 2021 Jan; 743():135566. PubMed ID: 33352289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.
    Tanaka K; Yagi T; Shimakoshi R; Azuma K; Nanba T; Ogo H; Tamura A; Asanuma M
    Neurosci Lett; 2009 Oct; 462(3):235-8. PubMed ID: 19615429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
    Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
    J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.
    Koola MM; Buchanan RW; Pillai A; Aitchison KJ; Weinberger DR; Aaronson ST; Dickerson FB
    Schizophr Res; 2014 Aug; 157(1-3):84-9. PubMed ID: 24878431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke.
    Hurtado O; Pradillo JM; Fernández-López D; Morales JR; Sobrino T; Castillo J; Alborch E; Moro MA; Lizasoain I
    Neurobiol Dis; 2008 Jan; 29(1):123-31. PubMed ID: 17884513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.